• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

Three Treatment Options To Consider

May 9, 2025

Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

May 9, 2025

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Sunday, May 11
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

    May 9, 2025

    OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

    May 9, 2025

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Health»Treatments for cramps don’t cut it. Why aren’t there better options?
Health

Treatments for cramps don’t cut it. Why aren’t there better options?

February 20, 2023No Comments8 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Treatments for cramps don't cut it. Why aren't there better options?
Share
Facebook Twitter LinkedIn Pinterest Email

One day last fall, Kiran’s period cramps became so painful they woke her up from a nap. The 19-year-old took some ibuprofen, but found little relief.

“The pain was so bad, it felt like someone was punching me,” said Kiran, who asked to be referred to by only her first name for privacy. It felt “like I was giving birth.”

The standard treatment for menstrual cramps — non-steroidal anti-inflammatory drugs (NSAIDs) like Midol, Motrin, and Aleve — provide Kiran with a few hours of relief at most, if they even work at all. She’s tried the other common treatment for cramps, hormonal birth control, but it gave her nausea and fatigue so severe she couldn’t stay on it.

advertisement

That intractable pain is a monthly reality for many others who menstruate. It’s estimated that nearly 1 in 5 people with dysmenorrhea — or painful periods with or without an underlying medical issue like endometriosis or uterine fibroids — don’t get relief from existing treatments.

And yet, period pain has long been seen as a solved problem. There’s little funding for research into dysmenorrhea. Studies of treatments that looked promising — including research on Viagra to treat menstrual pain — have all but stalled for lack of investment or participation from patients.

advertisement

The problem starts, experts said, with how unclear the science still is on the various causes of cramps. The prevailing theory behind cramps is a group of compounds called prostaglandins. At the beginning of menstruation, levels of the hormones progesterone and estradiol drop, leading to an increased production of prostaglandins. The compounds cause the uterus to contract to help it expel tissue, but may also cause painful cramps.

NSAIDs stop the production of prostaglandins. This should provide pain relief, especially if the drugs are taken before pain begins. The fact that they don’t work for everyone could be due to absorption issues, but it also hints that a different mechanism might be at play.

“In short, there are probably many mechanisms responsible for menstrual pain,” said Kevin Hellman, a menstrual pain researcher at the University of Chicago. Uterine contractions are a likely cause, and abdominal muscle soreness, inflamed tissue, pelvic floor muscle fatigue, and a number of other factors could also be at play, he said.

Having a better understanding of what’s causing the pain could help researchers develop more effective treatments. It could also help doctors know how to better treat those who don’t find relief from NSAIDs.

See also  Losing a spouse may be more lethal for men, finds study

“There’s a whole raft of these newer treatments that we can test out if we just know who to use them on,” said Frank Tu, an OB-GYN and menstrual pain researcher at NorthShore University HealthSystem.

Those include electrical stimulation, sensory integration therapy, and even cognitive behavioral therapy, but clinicians have no way to assess which patients might benefit from which treatments.

“I envision a future where, if a woman is not responding to a medication, we might be able to do a series of tests and provide some guidance on what treatment might help her,” Hellman said.

One of those possible treatments is the erectile dysfunction drug Viagra. Sildenafil citrate (the generic version of Viagra) increases blood flow by dilating blood vessels. Prostaglandins, the compounds blocked by NSAIDs, may build up inside the blood vessels in the uterus, which could contribute to pain.

Theoretically, dilating blood vessels in the uterus could “lead to kind of a flushing away of those painful stimulants,” said Richard Legro, an OB-GYN and reproductive endocrinology researcher at Penn State who launched a clinical trial in 2007 to study the treatment. He also hypothesized the drug could bring more oxygen to the uterus — low oxygen levels can change the local pH and stimulate nerve endings, leading to pain. That’s why tourniquets and blood pressure cuffs can be painful. Dilating blood vessels would make room for more fresh, oxygenated blood.

Participants received sildenafil citrate or a placebo drug — administered vaginally in the hopes of getting a stronger effect and bypassing any absorption issues — while menstruating.

The small study of 25 people produced promising results. At the beginning of the treatment, the participants rated their pain with an average of 93 on a 100-point scale. The average pain rating for the women who received sildenafil citrate decreased to 23 within two hours, and 9 after four hours. There was a placebo effect, however — pain for the women who received the placebo decreased to 73 within two hours and 51 by four hours.

But the study ran out of funding before Legro’s team could recruit enough participants, and Legro’s application for an additional grant from the National Institutes of Health has been rejected twice. Legro said the reviewers didn’t think dysmenorrhea was worth studying. “I just feel they’re out of touch with women’s health,” he said.

See also  ‘We Don’t Need 23,000 Employees’: Vivek Ramaswamy Calls For Federal Reserve Reform After Rate Hike

They also had issues with the study’s design, in which each participant would receive both the placebo drug and sildenafil citrate at different points. Yet the FDA has backed that study design, and outside experts who spoke to STAT said they did not have concerns about it. Legro said reviewers were unfamiliar with why it was a suitable design for a dysmenorrhea trial.

“Those were the two issues that still burn almost a decade later,” Legro said. Legro published his results in 2013 and the study hasn’t progressed since.

Chen X. Chen, a menstrual pain researcher at the Indiana University School of Nursing, has similarly struggled to get funding to expand on a promising line of research into how the vaginal microbiome might relate to dysmenorrhea symptoms. In 2019, Chen ran a small study of 20 women that found that those with more severe period pain had less “good” bacteria, and more bacteria linked to inflammation.

Chen’s applications for further grant funding have been rejected twice, and two other applications are still under review. “The other day I was joking with a colleague and said, ‘It’s a practice of resilience and perseverance to get a grant funded,’” Chen said.

Chen’s experience points to one of the primary challenges of menstrual pain research: securing funding. Much of the funding comes from the federal government, specifically the National Institute of Child Health and Human Development (NICHD) within the NIH.

“There’s no foundation to pay for menstrual pain research,” Hellman said. “There is for endometriosis, there is for fibromyalgia, there is for Crohn’s disease, but there’s no philanthropic organization to pay for menstrual pain research.”

The institution does support research into dysmenorrhea, and has even put out calls for more grant applications on the condition.

But “there is always a portion of people who review grants who don’t really see [dysmenorrhea] as necessarily that important, in part because NSAIDs work really well for a portion of the population,” said Laura Payne, a clinical psychologist at McLean Hospital who has received NICHD funding to study menstrual pain as a risk factor associated with developing chronic pain.

Even if they get funding, many menstrual pain studies struggle to recruit enough participants. The Viagra study recruited women for over three years, but only ever enrolled 25 of its targeted 62 participants.

See also  Millions Of Britons Avoid Penicillin — But Most Don’t Need To

The study participants must be willing to come into the lab when they are menstruating and in pain. “That is an incredible challenge,” Hellman said. “We’re willing to do that — we have a high cancellation rate — but it’s very hard. You have to be in contact with a large number of women and keep track of their cycles.”

Researchers are getting creative about how to carry on their work despite those challenges. Hellman developed an MRI technique to visualize what’s going on in the uterus during menstrual cramps. He is currently using the technique in a clinical trial to test whether NSAIDs stop contractions. If NSAIDs don’t work for someone, this method should reveal why. It could be a drug absorption issue, but if the person never had contractions to begin with, there may be a different cause for the pain.

Payne is studying how emotions and pain perception interact with dysmenorrhea. “There’s that emotional component to the pain experience that we know can make the pain experience worse,” she said. Some people with dysmenorrhea have a higher risk of developing chronic pain, and she is studying if pain perception plays a role. If it does, she said, cognitive behavioral therapy may stop chronic pain from emerging, although no research has demonstrated this yet.

And the Viagra study may get a second chance. Tu said he and Hellman, who frequently collaborate, still hope to pick the sildenafil citrate project back up. It’s all a matter of playing the funding game. Tu hopes to include a small sildenafil citrate study as part of a larger, multi-arm trial testing different treatments with a strong chance of approval, like sneaking vegetables into a picky eater’s favorite meal. He already does this with bladder pain and dysmenorrhea studies.

“We think it could be done,” Tu said. “We just have to be patient.” While he strategizes and waits for the right opportunity, people like Kiran will continue dealing with their pain, month after month. They’ll wait for new treatments too — just not as patiently.

This story is part of ongoing coverage of reproductive health care supported by a grant from the Commonwealth Fund. 

arent cramps cut Dont options treatments
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Three Treatment Options To Consider

May 9, 2025

‘I Never Met A Tax Cut I Didn’t Like’: Kudlow Examines Possible Benefits And Pitfalls Of Trump Tariffs

April 3, 2025

‘DEI Isn’t For Us’: Some Black-Owned Businesses Say Diversity Policies Don’t Work

February 18, 2025

Where Can I Find the Best Deals on Luxury Vinyl Flooring? 4 Options For Eco-Conscious Homeowners

February 14, 2025
Add A Comment

Leave A Reply Cancel Reply

Top Posts

FACT CHECK: Instagram Post Falsely Claims ‘Modified Mosquitoes Have Officially Made It To Ohio’

September 15, 2023

Biggest Bank In The US Scoops Up Execs From Failed Climate Bank

July 12, 2023

In Troubled Times, the Sports World Offers a Necessary Salve

February 20, 2023

Instacart to target valuation of up to $9.3 billion in IPO, source says

September 11, 2023
Don't Miss

Three Treatment Options To Consider

Lifestyle May 9, 2025

The most common cause of hair loss in men is male androgenetic alopecia (MAA), otherwise…

Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

May 9, 2025

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025

OpenAI CEO Warns: ‘Not A Huge Amount Of Time’ Until China Overpowers American AI

May 9, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,112)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,629)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

If Harvard President Claudine Gay Was a ‘White Male’ She Would Be Fired

December 13, 2023

Olympian Inga Thompson Says She Wants Female Athletes To ‘Protest’ Trans Cycling Policies

May 10, 2023

Dollar hits more than one-month high on China fears, yen drifts

August 14, 2023
Popular Posts

Three Treatment Options To Consider

May 9, 2025

Microsoft Bans Employees From Using ‘Chinese Propaganda’ Chatbot

May 9, 2025

How Smart Mattresses Improve Sleep Quality For Couples

May 9, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.